Want to see HK:9966 full AI Analyst Report?

Alphamab Oncology (9966) Revenue

2 Followers

Alphamab Oncology Revenue

Alphamab Oncology had a revenue of 271.54M in the quarter ending Jun 30, 2026, with 11.89%. This bring the company's revenue in the last twelve months to 514.22M, Increased -8.52%. In the fiscal year ending Dec 31, 2025, Alphamab Oncology had annual revenue of 551.58M with -13.83% growth.

Revenue (ttm)

514.22M

Revenue Growth

-31.77%

P/S Ratio

14.84

Revenue/Employee

HK$1,071,030

Employees

515

Market Cap

HK$8.18B

Revenue Chart

Revenue History

Fiscal End Date	Revenue	Change	Growth
Dec 31, 2025	551.58M	-88.50M	-13.83%
Dec 31, 2024	640.08M	421.31M	+192.58%
Dec 31, 2023	218.77M	51.93M	+31.12%
Dec 31, 2022	166.84M	20.82M	+14.26%
Dec 31, 2021	146.02M	―	+∞%
Dec 31, 2020	―	-4.99M	-100.00%
Dec 31, 2019	4.99M	5.73M	-779.18%
Dec 31, 2018	-735.00K	-1.96M	-160.10%
Dec 31, 2017	1.22M	―	―